December 9, 2022

New Center Will Support Diabetes and Obesity Research Initiatives

Through collaboration, the Center for Quantitative Metabolic Research will help improve Cleveland Clinic’s standing as a leader for Type 2 diabetes and obesity research

Clinician conversation

When notified that Cleveland Clinic’s NIH funding for diabetes and obesity ranked 39 out of 80, it was clear to Daniel Rotroff, PhD and Marcio Griebeler, MD, and, that we weren’t reaching our full potential. This was the impetus for the creation of the Center for Quantitative Metabolic Research, which will begin in January 2023. The center will help improve collaboration and research in the diabetes and obesity fields.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The mission of the Center is to promote transdisciplinary clinical research that will improve the prevention, detection and treatment of metabolic disorders. Dr. Rotroff will serve as the director of the Center, while Dr. Griebeler will act as the clinical director.

“The prevalence of Type 2 diabetes and obesity continues to increase and are linked to a vast array of other health problems with major impacts on the lives of patients and the health care system overall. Current treatments require a trial-and-error approach and tools that can provide personalized and targeted treatments for patients are desperately needed. This Center aims to bring together investigators that can come up with innovative strategies to deliver these tools,” says Dr. Rotroff.

“Overall, Cleveland Clinic has an excellent program for treating patients with obesity and diabetes,” says Dr. Griebeler. “But from the research perspective, we are not combining efforts, and many people are working on their own. We are likely missing opportunities here. So, the goal of this effort is to establish Cleveland Clinic as the leader for Type 2 diabetes and obesity research.”


A center that brings people together

To help further spark collaboration, the center will be under the umbrellas of both the Endocrinology & Metabolism Institute (EMI) and the Lerner Research Institute (LRI). This will ensure that researchers, endocrinologists, diabetologists and obesity specialists can come together to help plan and develop state-of-the-art translational research projects. One of the things Dr. Griebeler is most excited about is the Center’s ability to provide support at every step.

“When we were developing this idea, we wrote down a few objectives that we wanted to achieve with the Center,” explains Dr. Griebeler. “First, we want to foster creative solutions to clinical challenges and metabolic disorders. We want to assemble interdisciplinary investigative teams that can compete for NIH funding. And through both of those objectives, we expect to increase research output and drive innovation in patient care. So that’s kind of the idea; we’ll have these meetings where clinicians and researchers can come together and present their ideas and we can help them develop everything — the protocols, registries, support for pilot projects, data analysis and all those things required to do the research and make it competitive for external funding.”

“Ideally, this structure will be able to assist people who have identified a research gap somewhere but may not be sure how to get started or need to identify a collaborator that can give them that competitive edge,” says Dr. Rotroff. “For example, we can connect this person with someone who has an appropriate animal model or provide them with someone that can build machine-learning models, someone that can help them identify the right funding mechanism and prepare the grants. The center will help them with all those things. These kinds of things can be intimidating and difficult for people who are not well-versed in the grant proposal process or others may have an existing research program that could benefit from working with a collaborator that brings different expertise.”


Broad areas of expertise

An advisory board will help steer the Center and will be made up of specialists from a multitude of areas. Along with Drs. Rotroff and Griebeler, the other board members and their areas of expertise include:

  • Bartolome Burguera, MD, Chair of the Endocrinology and Metabolism Institute (EMI) at Cleveland Clinic Obesity, Diabetes
  • Serpil Erzurum, MD, Chief Research and Academic Officer of Cleveland Clinic – Clinical, Basic and Translational Research, Biomedical
  • Ali Aminian, MD, Director of the Bariatric and Metabolic Institute at Cleveland Clinic and Professor of Surgery at the Cleveland Clinic Lerner College of Medicine Bariatric Surgery
  • Mike Kattan, PhD, Chair, Department of Quantitative Health Sciences, Cleveland Clinic Prediction models, Biostatistics

“I think the opportunities for collaboration are especially exciting because sometimes we get stuck in our own little bubble, and we forget to seek out input from others that may foster new and fresh ideas,” says Dr. Rotroff. The Center will interface closely with other existing centers such as the Healthcare Delivery & Implementation Science Center, led by Anita Misra-Hebert, MD, and the Diabesity Center in the EMI. “I believe the best innovation happens when experts come together from different disciplines to share their own unique skillsets, perspectives, and expertise. That creates opportunities for totally new ideas to develop. It’s exciting to imagine the possibilities and the impact this could have on patients.”

Related Articles

Photo of patient injecting drug into stomach
February 22, 2024
Cleveland Clinic Study Identifies Factors Associated With Long-Term Use of Popular Anti-Obesity Medications

Perserverance may depend on several specifics, including medication type, insurance coverage and medium-term weight loss

22-CHP-3415472 CQD-Kim-Association between COVID and New-Onset Type 1 Diabetes650x450
February 1, 2023
COVID-19 and Diabetes in Pediatric Patients: What We Know

Evidence, clinical considerations, and why more research is still needed

22-ORI-3128608 CQD 650×450
September 27, 2022
‘Osteobesity’: How We’re Optimizing Patients with High BMI, Diabetes for Orthopaedic Surgery

New program bridges orthopaedics and endocrinology

endocrinology and geriatrics
March 22, 2023
Endocrine Care with a Focus on Aging Stronger, Faster, Better

Building the bridge between endocrinology and geriatrics

Patient counseling
May 19, 2022
Reducing the Transition Care Gap for Patients with Obesity

Cleveland Clinic’s Endocrinology & Metabolism Institute is working to better prepare pediatric patients with obesity for adult care, and a new fellowship program is one way they are closing the transition gap

October 19, 2021
Cleveland Clinic Surgical Team Performs First Right-Sided Robotic Liver Resection

Accessing the right side of the liver laparascopically involves several more challenges when compared to the left side of the liver

Neuroendocrine tumor micrograph
November 10, 2020
Adrenal and Neuroendocrine Tumor Center Streamlines Care With Multidisciplinary Approach

Harnessing diverse expertise and advanced technology to treat complex tumor types

November 13, 2019
Medical Weight Loss: Playing the Long Game

Nonsurgical weight loss and medical weight management program addresses comorbidities of obesity